Open AccessIs There a Need for a Better Basal Insulin?
Author(s) -
Richard A. Guthrie
Publication year - 2001
Publication title -
clinical diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.931
H-Index - 37
eISSN - 1945-4953
pISSN - 0891-8929
DOI - 10.2337/diaclin.19.2.66
Subject(s) - medicine , insulin glargine , insulin , type 2 diabetes , basal insulin , intensive care medicine , diabetes management , diabetes mellitus , basal (medicine) , endocrinology
IN BRIEF Basal insulin therapy is an integral part of intensive management of type 1 diabetes and is often used in conjunction with oral agent therapy for type 2 diabetes. Currently available insulins do not always provide adequate background coverage. Insulin glargine, a new product that will soon be available for commercial use, addresses this need by providing 24-h coverage without peaks or valleys.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom